NCT01714414
A Trial to Confirm a Sustained Virological Suppression Defined as HIV-RNA <50 Copies/ml of 3 Different Doses of Fozivudine in Context to a Standard Zidovudine Based Antiretroviral Therapy Regimen
Phase: Phase 2
Role: Collaborator
Start: Dec 31, 2012
Completion: Feb 28, 2017